Skip to main content
Signal8

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

$IMNMPress releaseJun 4, 2026, 4:02 PM ETRead the release

Immunome granted 353,000 stock options to 20 new employees as inducement awards under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $20.78, matching the closing price on June 1, 2026, and vest over four years.

Key figures

Offering Price
20.78
Shares Offered
353000
New employees
20
Vesting period years
4

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.